Assessing the Quality of Global Clinical Practice Guidelines on Gout Using AGREE II Instrument
- 9 November 2018
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in JCR: Journal of Clinical Rheumatology
- Vol. 26 (2), 54-59
- https://doi.org/10.1097/rhu.0000000000000921
Abstract
The aim of this study was to assess the quality of global clinical practice guidelines (CPGs) on gout. We systematically searched MEDLINE, CBM (Chinese Biomedical Literature database), GIN (Guidelines International Network), NICE (National Institute for Health and Clinical Excellence), NGC (National Guideline Clearinghouse), WHO (World Health Organization), SIGN (Scottish Intercollegiate Guidelines Network), DynaMed, UpToDate, and Best Practice databases from their inception until January 2017 to identify and select CPGs related to gout. Two reviewers independently assessed the eligible gout CPGs using the AGREE II instrument. We evaluated 15 CPGs published between 2007 and 2017, produced by 13 different developers. Quality of evidence and strength of recommendations were presented in 14 (93%) and 13 (87%) CPGs, respectively. The mean scores (±SD) for each AGREE II domain were as follows: (i) scope and purpose: 75% (±17%), (ii) stakeholder involvement: 39% (±19%), (iii) rigor of development: 43% (±17%), (iv) clarity and presentation: 82% (±14%), (v) applicability: 31% (±12%), and (vi) editorial independence: 23% (±29%). The quality of gout CPGs was suboptimal, and various incompatible grading systems of quality of evidence and strength of recommendations were used. The use of a standardized international grading system is essential to ensure high methodological quality of gout CPGs. Tools such as AGREE II could substantially improve the development and update of future gout CPGs.Keywords
This publication has 30 references indexed in Scilit:
- 2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritisArthritis Care & Research, 2012
- 2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care & Research, 2012
- Systematic review of the prevalence of gout and hyperuricaemia in AustraliaInternal Medicine Journal, 2012
- National prevalence of gout derived from administrative health data in Aotearoa New ZealandRheumatology, 2012
- Japanese Guideline for the Management of Hyperuricemia and Gout: Second EditionNucleosides, Nucleotides and Nucleic Acids, 2011
- Gout. Epidemiology of goutArthritis Research & Therapy, 2010
- AGREE II: Advancing guideline development, reporting, and evaluation in health carePreventive Medicine, 2010
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Independent Impact of Gout on Mortality and Risk for Coronary Heart DiseaseCirculation, 2007
- British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of GoutRheumatology, 2007